Literature DB >> 26760524

Alcohol withdrawal syndrome in medical patients.

Justine S Gortney1, Joshua N Raub2, Pragnesh Patel3, Lianne Kokoska4, Mae Hannawa5, Amy Argyris6.   

Abstract

The authors provide a critical review focusing on pharmacotherapy of alcohol withdrawal syndrome in hospitalized patients who are not critically ill. They outline recommendations for patient assessment and monitoring.
Copyright © 2016 Cleveland Clinic.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26760524     DOI： 10.3949/ccjm.83a.14061

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  6 in total

1.  Baclofen for alcohol withdrawal.

Authors:  Jia Liu; Lu-Ning Wang
Journal:  Cochrane Database Syst Rev       Date:  2019-11-06

2.  Effects of alcohol on c-Myc protein in the brain.

Authors:  Tunde Akinyeke; Sydney J Weber; April T Davenport; Erich J Baker; James B Daunais; Jacob Raber
Journal:  Behav Brain Res       Date:  2016-11-08       Impact factor: 3.332

3.  Phenobarbital Versus Lorazepam for Management of Alcohol Withdrawal Syndrome: A Retrospective Cohort Study.

Authors:  Fadi Hawa; Linsey Gilbert; Benjamin Gilbert; Vanessa Hereford; Aya Hawa; Alsadiq Al Hillan; Mark Weiner; Jeremy Albright; Caleb Scheidel; Ola Al-Sous
Journal:  Cureus       Date:  2021-02-11

4.  History of Delirium Tremens in AUD Patients in Treatment: Relationship to AUD Severity and Other Factors.

Authors:  Jørgen G Bramness; Susmita Pandey; Jenny Skumsnes Moe; Helge Toft; Lars Lien; Ingeborg Bolstad
Journal:  Subst Abuse Rehabil       Date:  2022-09-13

Review 5.  Substance use disorders: diagnosis and management for hospitalists.

Authors:  Ahmed K Pasha; Arnab Chowdhury; Sanah Sadiq; Jeremiah Fairbanks; Shirshendu Sinha
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-05-21

6.  Severe diaphoresis and fever during alcohol withdrawal cause hypovolemic shock: case report.

Authors:  Michitaka Funayama; Ryotaro Okochi; Shintaro Asada; Yusuke Shimizu; Shin Kurose; Taketo Takata
Journal:  BMC Psychiatry       Date:  2021-08-04       Impact factor: 3.630
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.